BIO's announced agreement with National Science Foundation (NSF) to bring SBIR-funded, early-stage biotech companies to present at BIO Investor Forum 2013. Presenting companies in NSF track include ADMdx, Biodesy, Carmot, CertiChem, Jade Therapeutics, Nano3D Biosciences, Nanofiber Solutions, Parabon Nanolabs, Stemina, and Tymora Analytical Operations. All are funded by NSF and focused on drug discovery, diagnostics, and other platform technologies.